Skip to content
10-K

Annual Report

MYRIAD GENETICS INC MYGN

0000899923-25-000019

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 21, 2025 91.31M sh
Long Term Debt FY 2024 · Dec 31, 2023 $38.5M
Current Liabilities FY 2024 · Dec 31, 2023 $155.9M
Total Liabilities FY 2024 · Dec 31, 2023 $363.3M
Current Assets FY 2024 · Dec 31, 2023 $313.6M
Total Assets FY 2024 · Dec 31, 2023 $1.15B
Stock Issued FY 2024 · Dec 31, 2022 0 sh
Shares Diluted FY 2024 · Dec 31, 2022 80.6M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −$106.3M
Cash And Equivalents FY 2024 · Dec 31, 2022 $56.9M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.39
Eps Basic FY 2024 · Dec 31, 2022 −$1.39
Rd Expense FY 2024 · Dec 31, 2022 $85.4M
Net Income FY 2024 · Dec 31, 2022 −$112M
Operating Income FY 2024 · Dec 31, 2022 −$140.6M
Gross Profit FY 2024 · Dec 31, 2022 $476.4M
Revenue FY 2024 · Dec 31, 2022 $678.4M
Stockholders Equity FY 2024 · Dec 31, 2021 $967.8M